부산대학교 도서관

Parikh AR; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Chee BH; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, California.; Tsai J; Guardant Health, Palo Alto, California.; Rich TA; Guardant Health, Palo Alto, California.; Price KS; Guardant Health, Palo Alto, California.; Patel SA; Guardant Health, Palo Alto, California.; Zhang L; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, California.; Department of Medicine, University of California, San Francisco, San Francisco, California.; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California.; Ibrahim F; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, California.; Esquivel M; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, California.; Van Seventer EE; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, California.; Jarnagin JX; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Raymond VM; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Corvera CU; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, California.; Department of Surgery, University of California, San Francisco, San Francisco, California.; Hirose K; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, California.; Department of Surgery, University of California, San Francisco, San Francisco, California.; Nakakura EK; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, California.; Department of Surgery, University of California, San Francisco, San Francisco, California.; Corcoran RB; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Van Loon K; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, California.; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, California.; Atreya CE; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, California.; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, California.

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Corcoran RB; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Do KT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Kim JE; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.; Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Parikh AR; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Yeku OO; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Xiong N; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Weekes CD; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Veneris J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ahronian LG; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Mauri G; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, and Department of Hematology Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Tian J; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Norden BL; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Michel AG; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Van Seventer EE; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Siravegna G; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Camphausen K; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Chi G; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Fetter IJ; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Brugge JS; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts.; Chen H; National Institute of Health, National Cancer Institute, Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, Bethesda, Maryland.; Takebe N; National Institute of Health, National Cancer Institute, Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, Bethesda, Maryland.; Penson RT; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Juric D; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Flaherty KT; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Sullivan RJ; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Clark JW; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Heist RS; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Matulonis UA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Liu JF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Jarnagin JX; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.; Saraf A; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston.; Baiev I; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.; Chi G; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.; van Seventer EE; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.; Mojtahed A; Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston.; Allen JN; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.; Clark JW; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.; Blaszkowsky L; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.; Giantonio BJ; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.; Weekes CD; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.; Klempner SJ; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.; Franses JW; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.; Roeland EJ; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.; Goyal L; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.; Siravegna G; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.; Horick N; Department of Statistics, Massachusetts General Hospital and Harvard Medical School, Boston.; Corcoran RB; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.; Nipp RD; OU Health Stephenson Cancer Center, Section of Hematology and Oncology, Department of Internal Medicine, The University of Oklahoma (OU) College of Medicine, Oklahoma City.; Parikh AR; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Tian J; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Chen JH; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.; Chao SX; The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.; Pelka K; The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.; Gladstone-UCSF Institute of Genomic Immunology, Gladstone Institutes Department of Microbiology and Immunology, UCSF, San Francisco, CA, USA.; Giannakis M; Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Hess J; The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.; Burke K; Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Jorgji V; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Sindurakar P; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Braverman J; The Koch Institute, Massachusetts Institute of Technology, Cambridge, MA, USA.; Mehta A; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.; Oka T; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Huang M; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Lieb D; The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.; Spurrell M; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Allen JN; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Abrams TA; Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Clark JW; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Enzinger AC; Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Enzinger PC; Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Klempner SJ; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; McCleary NJ; Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Meyerhardt JA; Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Ryan DP; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Yurgelun MB; Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Kanter K; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Van Seventer EE; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Baiev I; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Chi G; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Jarnagin J; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Bradford WB; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Wong E; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Michel AG; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Fetter IJ; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Siravegna G; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Gemma AJ; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Sharpe A; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Demehri S; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Leary R; Novartis Institute for Biomedical Research, Cambridge, MA, USA.; Campbell CD; Novartis Institute for Biomedical Research, Cambridge, MA, USA.; Yilmaz O; The Koch Institute, Massachusetts Institute of Technology, Cambridge, MA, USA.; Getz GA; The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.; Parikh AR; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Hacohen N; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA. NHACOHEN@mgh.harvard.edu.; The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA. NHACOHEN@mgh.harvard.edu.; Corcoran RB; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA. rbcorcoran@partners.org.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Rajurkar M; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Parikh AR; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Solovyov A; Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.; You E; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Kulkarni AS; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Chu C; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.; Xu KH; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Jaicks C; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Taylor MS; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Wu C; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Wyss Institute for Biologically Inspired Engineering, Harvard Medical School, Boston, Massachusetts.; Alexander KA; Epigenetics Institute, Departments of Cell and Developmental Biology, Genetics, and Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Good CR; Epigenetics Institute, Departments of Cell and Developmental Biology, Genetics, and Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Szabolcs A; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Gerstberger S; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Tran AV; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.; Xu N; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Ebright RY; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Van Seventer EE; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Vo KD; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Tai EC; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Lu C; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Joseph-Chazan J; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Raabe MJ; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Nieman LT; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Desai N; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Arora KS; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Ligorio M; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Thapar V; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Cohen L; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Wyss Institute for Biologically Inspired Engineering, Harvard Medical School, Boston, Massachusetts.; Garden PM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Wyss Institute for Biologically Inspired Engineering, Harvard Medical School, Boston, Massachusetts.; Senussi Y; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Wyss Institute for Biologically Inspired Engineering, Harvard Medical School, Boston, Massachusetts.; Zheng H; Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts.; Allen JN; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Blaszkowsky LS; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Clark JW; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Goyal L; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Wo JY; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Ryan DP; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Corcoran RB; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Deshpande V; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Rivera MN; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Aryee MJ; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Hong TS; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Berger SL; Epigenetics Institute, Departments of Cell and Developmental Biology, Genetics, and Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Walt DR; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Wyss Institute for Biologically Inspired Engineering, Harvard Medical School, Boston, Massachusetts.; Burns KH; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Park PJ; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.; Greenbaum BD; Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.; Physiology, Biophysics and Systems Biology, Weill Cornell Medicine, Weill Cornell Medical College, New York, New York.; Ting DT; Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Marquardt JP; Department of Radiology, RWTH Aachen University, Aachen, Germany.; Department of Radiology, Division of Thoracic Imaging and Intervention, Massachusetts General Hospital, Boston, MA, USA.; Roeland EJ; Knight Cancer Institute, Oregon Health and Sciences University, Portland, OR, USA.; Van Seventer EE; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Best TD; Department of Radiology, Division of Thoracic Imaging and Intervention, Massachusetts General Hospital, Boston, MA, USA.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Radiology, Berlin, Germany.; Horick NK; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Nipp RD; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Fintelmann FJ; Department of Radiology, Division of Thoracic Imaging and Intervention, Massachusetts General Hospital, Boston, MA, USA.

Publisher: John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders Country of Publication: Germany NLM ID: 101552883 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2190-6009 (Electronic) Linking ISSN: 21905991 NLM ISO Abbreviation: J Cachexia Sarcopenia Muscle Subsets: MEDLINE

Loomans-Kropp HA; Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, MD 20850.; Gastrointestinal and Other Cancers Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, MD 20850.; Song Y; Cancer ImmunoPrevention Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD 21702.; Gala M; Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.; Parikh AR; Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.; Van Seventer EE; Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.; Alvarez R; Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048.; Hitchins MP; Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048.; Shoemaker RH; Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, MD 20850.; Umar A; Gastrointestinal and Other Cancers Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, MD 20850.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun

Kanter K; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA.; Fish M; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA.; Mauri G; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA.; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Dipartimento di Oncologia e Emato-Oncologia, Università degli Studi di Milano (La Statale), Milan, Italy.; Horick NK; Department of Statistics, Massachusetts General Hospital & Harvard Medical School, Boston, MA.; Allen JN; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA.; Blaszkowsky LS; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA.; Clark JW; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA.; Ryan DP; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA.; Nipp RD; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA.; Giantonio BJ; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA.; Goyal L; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA.; Dubois J; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA.; Murphy JE; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA.; Franses J; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA.; Klempner SJ; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA.; Roeland EJ; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA.; Weekes CD; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA.; Wo JY; Department of Radiation Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, MA.; Hong TS; Department of Radiation Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, MA.; Van Seventer EE; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA.; Corcoran RB; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA.; Parikh AR; Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

Parikh AR; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Szabolcs A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Allen JN; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Clark JW; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Wo JY; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Raabe M; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Thel H; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Hoyos D; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Mehta A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; The Broad Institute, Cambridge, MA, USA.; Arshad S; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Lieb DJ; The Broad Institute, Cambridge, MA, USA.; Drapek LC; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Blaszkowsky LS; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Giantonio BJ; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Weekes CD; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Zhu AX; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Goyal L; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Nipp RD; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Dubois JS; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Van Seventer EE; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Foreman BE; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Matlack LE; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Ly L; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Meurer JA; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Hacohen N; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; The Broad Institute, Cambridge, MA, USA.; Ryan DP; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Yeap BY; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Corcoran RB; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Greenbaum BD; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Ting DT; Department of Medicine, Division of Hematology & Oncology, Harvard Medical School, Boston, MA, USA. dting1@mgh.harvard.edu.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. dting1@mgh.harvard.edu.; Hong TS; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. tshong1@mgh.harvard.edu.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE

Parikh AR; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Van Seventer EE; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Siravegna G; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Hartwig AV; Guardant Health, Inc, Redwood City, California.; Jaimovich A; Guardant Health, Inc, Redwood City, California.; He Y; Guardant Health, Inc, Redwood City, California.; Kanter K; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Fish MG; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Fosbenner KD; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Miao B; Department of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts.; Phillips S; Department of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts.; Carmichael JH; Department of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts.; Sharma N; Department of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts.; Jarnagin J; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Baiev I; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Shah YS; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Fetter IJ; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Shahzade HA; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Allen JN; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Blaszkowsky LS; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Clark JW; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Dubois JS; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Franses JW; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Giantonio BJ; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Goyal L; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Klempner SJ; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Nipp RD; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Roeland EJ; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Ryan DP; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Weekes CD; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Wo JY; Department of Radiation Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Hong TS; Department of Radiation Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Bordeianou L; Department of General and Gastrointestinal Surgery, Massachusetts General Hospital, Boston, Massachusetts.; Ferrone CR; Department of General and Gastrointestinal Surgery, Massachusetts General Hospital, Boston, Massachusetts.; Qadan M; Department of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts.; Kunitake H; Department of General and Gastrointestinal Surgery, Massachusetts General Hospital, Boston, Massachusetts.; Berger D; Department of General and Gastrointestinal Surgery, Massachusetts General Hospital, Boston, Massachusetts.; Ricciardi R; Department of General and Gastrointestinal Surgery, Massachusetts General Hospital, Boston, Massachusetts.; Cusack JC; Department of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts.; Raymond VM; Guardant Health, Inc, Redwood City, California.; Talasaz A; Guardant Health, Inc, Redwood City, California.; Boland GM; Department of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts.; Corcoran RB; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts. rbcorcoran@partners.org.

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE